Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Chlamydia pneumoniae activates nuclear factor kappaB and activator protein 1 in human vascular smooth muscle and induces cellular proliferation.

Miller SA, Selzman CH, Shames BD, Barton HA, Johnson SM, Harken AH.

J Surg Res. 2000 May 1;90(1):76-81.

PMID:
10781378
2.
3.

Atherogenic effects of Chlamydia pneumoniae: refuting the innocent bystander hypothesis.

Selzman CH, Netea MG, Zimmerman MA, Weinberg A, Reznikov LL, Grover FL, Dinarello CA.

J Thorac Cardiovasc Surg. 2003 Sep;126(3):688-93.

4.

Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation.

Dechend R, Gieffers J, Dietz R, Joerres A, Rupp J, Luft FC, Maass M.

Circulation. 2003 Jul 22;108(3):261-5. Epub 2003 Jul 14.

PMID:
12860900
5.

Chlamydia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous heat shock protein 60.

Hirono S, Dibrov E, Hurtado C, Kostenuk A, Ducas R, Pierce GN.

Circ Res. 2003 Oct 17;93(8):710-6. Epub 2003 Sep 18.

PMID:
14500333
6.

Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1.

Viedt C, Vogel J, Athanasiou T, Shen W, Orth SR, Kübler W, Kreuzer J.

Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):914-20.

PMID:
12067898
7.

Requirement for NF-kappaB in transcriptional activation of monocyte chemotactic protein 1 by Chlamydia pneumoniae in human endothelial cells.

Molestina RE, Miller RD, Lentsch AB, Ramirez JA, Summersgill JT.

Infect Immun. 2000 Jul;68(7):4282-8.

8.

Vascular smooth muscle cell activation by C-reactive protein.

Hattori Y, Matsumura M, Kasai K.

Cardiovasc Res. 2003 Apr 1;58(1):186-95.

PMID:
12667961
9.

Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation.

Selzman CH, Miller SA, Zimmerman MA, Gamboni-Robertson F, Harken AH, Banerjee A.

Am J Physiol Heart Circ Physiol. 2002 Oct;283(4):H1455-61. Epub 2002 Jun 20.

10.

Role of P38 MAPK, AP-1, and NF-kappaB in interleukin-1beta-induced IL-8 expression in human vascular smooth muscle cells.

Jung YD, Fan F, McConkey DJ, Jean ME, Liu W, Reinmuth N, Stoeltzing O, Ahmad SA, Parikh AA, Mukaida N, Ellis LM.

Cytokine. 2002 May 21;18(4):206-13.

PMID:
12126643
11.

Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin.

Chandrasekar B, Mummidi S, Mahimainathan L, Patel DN, Bailey SR, Imam SZ, Greene WC, Valente AJ.

J Biol Chem. 2006 Jun 2;281(22):15099-109. Epub 2006 Mar 22.

12.

Aspirin inhibits Chlamydia pneumoniae-induced nuclear factor-kappa B activation, cytokine expression, and bacterial development in human endothelial cells.

Tiran A, Gruber HJ, Graier WF, Wagner AH, Van Leeuwen EB, Tiran B.

Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1075-80.

PMID:
12117719
13.
16.

Reactive oxygen and NF-kappaB in VEGF-induced migration of human vascular smooth muscle cells.

Wang Z, Castresana MR, Newman WH.

Biochem Biophys Res Commun. 2001 Jul 20;285(3):669-74.

PMID:
11453645
17.

HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.

Viedt C, Shen W, Fei J, Kamimura M, Hänsch GM, Katus HA, Kreuzer J.

Basic Res Cardiol. 2003 Nov;98(6):353-61. Epub 2003 Sep 22.

PMID:
14556080
18.

Chlamydia pneumoniae activates epithelial cell proliferation via NF-kappaB and the glucocorticoid receptor.

Gencay MM, Tamm M, Glanville A, Perruchoud AP, Roth M.

Infect Immun. 2003 Oct;71(10):5814-22.

19.

Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1.

Chen Y, Budd RC, Kelm RJ Jr, Sobel BE, Schneider DJ.

Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1777-83. Epub 2006 May 18.

PMID:
16709941

Supplemental Content

Support Center